VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TXG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TXG10x Genomics, Inc.
$37.83$4.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTXGQuarterly Financials

10x Genomics, Inc. (TXG) Quarterly Financials

120+ quarters historyFree accessUpdated daily

10x Genomics, Inc. (TXG) quarterly income statement — complete revenue, gross profit & net income history

TXG Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue150.84M166.03M149M172.91M154.88M165.02M151.65M153.1M141.01M183.98M153.64M146.82M134.28M156.23M131.07M114.61M114.5M143.53M125.3M115.84M
Revenue Growth %-2.61%0.61%-1.75%12.93%9.84%-10.3%-1.3%4.28%5%17.76%17.22%28.1%17.28%8.85%4.61%-1.06%8.2%27.9%74.47%170%
Cost of Goods Sold44.66M52.98M48.7M47.82M49.44M54.07M45.26M48.88M48.09M68.2M58.12M47.21M35.9M36.83M30.38M27.7M25.48M27.6M24.52M4.92M
COGS % of Revenue29.61%31.91%32.68%27.66%31.92%32.76%29.84%31.93%34.11%37.07%37.82%32.15%26.73%23.57%23.18%24.17%22.25%19.23%19.57%4.24%
Gross Profit106.18M113.05M100.31M125.08M105.44M110.95M106.39M104.22M92.91M115.78M95.53M99.61M98.39M119.41M100.69M86.91M89.02M115.93M100.78M110.93M
Gross Margin %70.39%68.09%67.32%72.34%68.08%67.24%70.16%68.07%65.89%62.93%62.18%67.85%73.27%76.43%76.82%75.83%77.75%80.77%80.43%95.76%
Gross Profit Growth %0.7%1.88%-5.72%20.02%13.49%-4.17%11.37%4.63%-5.57%-3.03%-5.13%14.62%10.53%3%-0.08%-21.66%0.29%24.23%75.55%237.65%
Operating Expenses123.22M132.59M132.55M94.96M144.77M160.79M147.88M145.96M154.41M170.97M190.32M162.97M150.38M142.5M140.69M150.02M130.75M131.76M116.66M121.25M
OpEx % of Revenue81.69%79.86%88.96%54.92%93.47%97.44%97.51%95.33%109.51%92.93%123.87%111%111.98%91.21%107.34%130.9%114.2%91.8%93.11%104.67%
Selling, General & Admin66.38M76.62M75.36M74.43M89.73M93.83M81.7M83.04M85.77M86.13M82.42M91.51M83.28M78.89M73.4M79.34M66.67M69.88M62.08M68.7M
SG&A % of Revenue44%46.15%50.57%43.05%57.93%56.86%53.88%54.24%60.83%46.81%53.64%62.33%62.02%50.49%56%69.22%58.23%48.68%49.54%59.31%
Research & Development56.85M55.97M57.19M61.22M64.25M66.97M66.17M62.92M68.64M65.27M107.91M71.46M67.1M63.61M67.29M70.69M64.08M61.88M54.58M53.4M
R&D % of Revenue37.69%33.71%38.38%35.41%41.48%40.58%43.63%41.09%48.68%35.48%70.23%48.67%49.97%40.72%51.34%61.67%55.97%43.12%43.56%46.1%
Other Operating Expenses000-1000K-1000K00001000K000000000-850K
Operating Income-17.05M-19.54M-32.24M30.13M-39.33M-49.84M-41.48M-41.74M-61.5M-55.19M-94.8M-63.36M-51.99M-23.1M-40M-63.12M-41.73M-15.83M-15.88M-10.33M
Operating Margin %-11.3%-11.77%-21.64%17.42%-25.39%-30.2%-27.36%-27.26%-43.61%-30%-61.7%-43.15%-38.71%-14.78%-30.51%-55.07%-36.45%-11.03%-12.67%-8.92%
Operating Income Growth %56.66%60.79%22.28%172.18%36.05%9.69%56.24%34.13%-18.29%-138.95%-137.01%-0.38%-24.57%-45.9%-151.88%-511.13%-308.53%96.14%75.67%73.8%
EBITDA-17.05M-19.54M-19.99M39.78M-29.51M-39.27M-30.73M-30.84M-50M-43.48M-83.38M-51.48M-43.37M-14.62M-31.88M-54.67M-33.76M-8.51M-8.6M-3.14M
EBITDA Margin %-11.3%-11.77%-13.42%23%-19.06%-23.8%-20.27%-20.14%-35.46%-23.63%-54.27%-35.06%-32.3%-9.36%-24.32%-47.7%-29.49%-5.93%-6.87%-2.71%
EBITDA Growth %42.24%50.25%34.96%228.99%40.98%9.68%63.14%40.1%-15.29%-197.33%-161.52%5.84%-28.47%-71.93%-270.54%-1640.62%-800.75%97.9%85.75%91.01%
D&A (Non-Cash Add-back)0012.25M9.65M9.81M10.56M10.75M10.9M11.49M11.71M11.42M11.88M8.62M8.47M8.12M8.44M7.97M7.32M7.28M7.19M
EBIT-17.05M-19.54M-28.2M37M-33.51M-48.38M-34.44M-37.08M-57.8M-46.59M-91.74M-60.76M-49.63M-16.29M-39.92M-63.72M-41.57M-15.78M-16.43M-9.75M
Net Interest Income5.01M5.49M5.2M4.27M3.69M4.03M4.97M4.71M4.74M4.63M4.3M4.09M3.85M2.69M1.91M1.13M441K-168K-170K-151K
Interest Income5.01M5.49M5.2M4.27M3.69M4.03M4.97M4.71M4.74M4.64M4.3M4.1M3.87M2.81M2.02M1.24M569K49K49K58K
Interest Expense003K3K002K1K1K8K1K5K19K125K114K109K128K217K219K209K
Other Income/Expense4.2M4.35M4.04M6.87M5.82M1.46M7.05M4.66M3.69M8.59M3.05M2.59M2.33M6.68M-39K-714K41K-163K-769K370K
Pretax Income-12.85M-15.19M-28.2M37M-33.51M-48.38M-34.44M-37.08M-57.8M-46.6M-91.74M-60.77M-49.65M-16.41M-40.03M-63.83M-41.69M-15.99M-16.65M-9.96M
Pretax Margin %-8.52%-9.15%-18.93%21.4%-21.63%-29.32%-22.71%-24.22%-40.99%-25.33%-59.71%-41.39%-36.98%-10.5%-30.54%-55.69%-36.42%-11.14%-13.29%-8.6%
Income Tax623K1.06M-733K2.46M852K648K1.31M818K2.15M2.35M1.24M1.65M1.09M804K1.88M627K719K2.46M523K1.09M
Effective Tax Rate %-4.85%-6.97%2.6%6.65%-2.54%-1.34%-3.82%-2.21%-3.71%-5.05%-1.35%-2.71%-2.2%-4.9%-4.69%-0.98%-1.72%-15.36%-3.14%-10.99%
Net Income-13.47M-16.25M-27.47M34.54M-34.36M-49.03M-35.75M-37.9M-59.95M-48.95M-92.99M-62.41M-50.75M-17.21M-41.91M-64.46M-42.41M-18.45M-17.17M-11.05M
Net Margin %-8.93%-9.79%-18.44%19.97%-22.18%-29.71%-23.58%-24.75%-42.52%-26.61%-60.52%-42.51%-37.79%-11.02%-31.98%-56.24%-37.04%-12.85%-13.7%-9.54%
Net Income Growth %60.8%66.85%23.16%191.14%42.69%-0.16%61.55%39.28%-18.13%-184.36%-121.85%3.17%-19.65%6.69%-144.1%-483.22%-267.18%95.56%73.92%72.48%
Net Income (Continuing)-13.47M-16.25M-27.47M34.54M-34.36M-49.03M-35.75M-37.9M-59.95M-48.95M-92.99M-62.41M-50.75M-17.21M-41.91M-64.46M-42.41M-18.45M-17.17M-11.05M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.10-0.13-0.220.28-0.28-0.40-0.30-0.32-0.50-0.41-0.79-0.53-0.44-0.15-0.37-0.57-0.38-0.16-0.15-0.10
EPS Growth %64.29%67.5%26.67%187.5%44%2.44%62.03%39.62%-13.64%-173.33%-113.51%7.02%-15.79%6.25%-146.67%-470%-245.45%95.87%76.92%75.61%
EPS (Basic)-0.10-0.13-0.220.28-0.28-0.40-0.30-0.32-0.50-0.41-0.79-0.53-0.44-0.15-0.37-0.57-0.38-0.16-0.15-0.10
Diluted Shares Outstanding128.29M127.08M125.5M124.51M122.61M121.6M120.73M120.07M119.39M118.57M117.73M116.71M115.62M114.76M114.11M113.57M112.97M111.9M110.87M109.87M
Basic Shares Outstanding128.29M127.08M125.5M123.76M122.61M121.6M120.73M120.07M119.39M118.57M117.73M116.71M115.62M114.76M114.11M113.57M112.97M111.9M110.87M109.87M
Dividend Payout Ratio--------------------